These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 29208204

  • 21. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
    Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC.
    Transplantation; 2019 Dec; 103(12):2666-2674. PubMed ID: 30883456
    [Abstract] [Full Text] [Related]

  • 22. Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step.
    Lachmann N, Duerr M, Schönemann C, Pruß A, Budde K, Waiser J.
    J Immunol Res; 2017 Dec; 2017():6872046. PubMed ID: 28255562
    [Abstract] [Full Text] [Related]

  • 23. The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis.
    Wan SS, Ying TD, Wyburn K, Roberts DM, Wyld M, Chadban SJ.
    Transplantation; 2018 Apr; 102(4):557-568. PubMed ID: 29315141
    [Abstract] [Full Text] [Related]

  • 24. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
    Pearl MH, Nayak AB, Ettenger RB, Puliyanda D, Palma Diaz MF, Zhang Q, Reed EF, Tsai EW.
    Pediatr Nephrol; 2016 Aug; 31(8):1341-8. PubMed ID: 27048228
    [Abstract] [Full Text] [Related]

  • 25. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK, Hussain SM, Marcus RJ, Ko TY, Khan AS, Tom K, Vivas CA, Parris G, Jasnosz KM, Thai NL.
    Clin Nephrol; 2012 Mar; 77(3):246-53. PubMed ID: 22377258
    [Abstract] [Full Text] [Related]

  • 26. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.
    Schwaiger E, Regele H, Wahrmann M, Werzowa J, Haidbauer B, Schmidt A, Böhmig GA.
    Clin Transpl; 2010 Mar; ():391-6. PubMed ID: 21696056
    [Abstract] [Full Text] [Related]

  • 27. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
    De Sousa-Amorim E, Revuelta I, Diekmann F, Cofan F, Lozano M, Cid J, Palou E, Sole M, Campistol JM, Oppenheimer F.
    Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
    [Abstract] [Full Text] [Related]

  • 28. Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation.
    Naciri Bennani H, Daligault M, Noble J, Bardy B, Motte L, Giovannini D, Emprou C, Fiard G, Imerzoukene F, Bourdin A, Masson D, Janbon B, Malvezzi P, Rostaing L, Jouve T.
    J Clin Apher; 2021 Aug; 36(4):584-594. PubMed ID: 33783868
    [Abstract] [Full Text] [Related]

  • 29. Therapy Modalities for Antibody Mediated Rejection in Renal Transplant Patients.
    Yilmaz VT, Suleymanlar G, Koksoy S, Ulger BV, Ozdem S, Akbas H, Akkaya B, Kocak H.
    J Invest Surg; 2016 Oct; 29(5):282-8. PubMed ID: 27002854
    [Abstract] [Full Text] [Related]

  • 30. Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies.
    Zhu L, Guo Z, Sa R, Guo H, Li J, Chen G.
    Front Immunol; 2021 Oct; 12():661614. PubMed ID: 33936098
    [Abstract] [Full Text] [Related]

  • 31. Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide.
    Waiser J, Duerr M, Budde K, Rudolph B, Wu K, Bachmann F, Halleck F, Schönemann C, Lachmann N.
    Transplantation; 2017 Oct; 101(10):2545-2552. PubMed ID: 28009783
    [Abstract] [Full Text] [Related]

  • 32. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL, Murillo D.
    Clin Transpl; 2011 Oct; ():401-8. PubMed ID: 22755438
    [Abstract] [Full Text] [Related]

  • 33. Acute Anti-A/B Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplantation Treated With Bortezomib and Plasmapheresis: A Case Report.
    Lee JH, Lee H, Kim K, Lee SW, Song JH, Hwang SD.
    Transplant Proc; 2022 Mar; 54(2):540-543. PubMed ID: 35067375
    [Abstract] [Full Text] [Related]

  • 34. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 35. Durability of antibody removal following proteasome inhibitor-based therapy.
    Everly MJ, Terasaki PI, Trivedi HL.
    Transplantation; 2012 Mar 27; 93(6):572-7. PubMed ID: 22262128
    [Abstract] [Full Text] [Related]

  • 36. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 37. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.
    Hum Immunol; 2013 Sep 27; 74(9):1111-8. PubMed ID: 23792054
    [Abstract] [Full Text] [Related]

  • 38. Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings.
    de Sousa MV, Gonçalez AC, de Lima Zollner R, Mazzali M.
    Ann Transplant; 2020 Nov 17; 25():e925488. PubMed ID: 33199675
    [Abstract] [Full Text] [Related]

  • 39. Treatment of antibody-mediated rejection in renal transplant patients: a clinical practice survey.
    Burton SA, Amir N, Asbury A, Lange A, Hardinger KL.
    Clin Transplant; 2015 Feb 17; 29(2):118-23. PubMed ID: 25430052
    [Abstract] [Full Text] [Related]

  • 40. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M, Coitiño R, Kurdian M, Orihuela L, Astesiano R, Garau M, López D, Rievas G, Rodriguez I, González-Martínez F, Noboa O.
    Transplant Proc; 2016 Mar 17; 48(2):612-5. PubMed ID: 27110014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.